Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- CheckyesterdayChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, replacing the details with a standard error screen. This indicates that access to the record is blocked on the site.SummaryDifference17%

- Check22 days agoChange DetectedThe study page now includes the topic Schizophrenia and related topics MedlinePlus Genetics, and the site revision changed from v3.6.6 to v3.7.0.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision: v3.6.6 was added to the page. The previous Revision: v3.6.5 reference and related topics such as Schizophrenia and MedlinePlus Genetics were removed.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now adds related topics entries for Schizophrenia and MedlinePlus Genetics to connect readers with additional background resources.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor version bump. This change updates the page's revision label but does not alter visible content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.